Volume 9, Issue 1 (June 2023)
Elderly Health Journal 2023, 9(1): 9-15 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Davari R, Morowatisharifabad M A, Beigomi A, Jambarsang S. Medication Use Status and Its Related Factors among Older Adults in Kerman, Iran. Elderly Health Journal 2023; 9 (1) :9-15
URL: http://ehj.ssu.ac.ir/article-1-256-en.html
URL: http://ehj.ssu.ac.ir/article-1-256-en.html
Department of Aging and Health, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , morowatisharif@yahoo.com
Abstract: (472 Views)
Introduction: Older adults are the largest group of medication users in each society. Since medications act differently in seniors compared with younger patients, great considerations are required regarding the effects and side effects of medications in the older adults. The present study aimed to determine the status of medication use and its related factors among older adults in Kerman city, Iran.
Methods: In the cross-sectional study, 388 seniors were selected using multistage cluster sampling from the population covered by comprehensive health centers in Kerman in 2021. Demographic information questions (age, gender, education level, marital status, life status, substance abuse, income, and health insurance status), a question regarding medication usage status and a question regarding disease that the elderly are currently suffering from, Montreal Cognitive Assessment Questionnaire, Geriatric Depression Scale, and Sleep Disorder Questionnaire were used for data collection. The data were analyzed using SPSS software by running Chi-square and multiple logistic regression tests.
Results: The average number of medications used per day was 4.59 and 53.5% of the participants used five or more medications concomitantly. Antihypertensive medications had the highest prevalence (64.3%) followed by anti-hyperlipidemic (43.6%) and Supplements (41.3%). A significant correlation was found between the participants' frequency of medication use and their gender, income, primary insomnia, and cognitive impairment (p < 0.001). However, medication use had no significant association with the senior's age, marital status, education level, living status, substance abuse, and health insurance (p < 0.05). The risk of polypharmacy was 2.15 times higher in the elderly women than men (p = 0.001) and 0.45 times higher in participants with depression than non-depressed seniors (p = 0.011).
Conclusion: The high prevalence of polypharmacy indicates an unfavorable status of medication use among older adults in Kerman. So, authorities are required to provide educational information about polypharmacy to aged groups.
Methods: In the cross-sectional study, 388 seniors were selected using multistage cluster sampling from the population covered by comprehensive health centers in Kerman in 2021. Demographic information questions (age, gender, education level, marital status, life status, substance abuse, income, and health insurance status), a question regarding medication usage status and a question regarding disease that the elderly are currently suffering from, Montreal Cognitive Assessment Questionnaire, Geriatric Depression Scale, and Sleep Disorder Questionnaire were used for data collection. The data were analyzed using SPSS software by running Chi-square and multiple logistic regression tests.
Results: The average number of medications used per day was 4.59 and 53.5% of the participants used five or more medications concomitantly. Antihypertensive medications had the highest prevalence (64.3%) followed by anti-hyperlipidemic (43.6%) and Supplements (41.3%). A significant correlation was found between the participants' frequency of medication use and their gender, income, primary insomnia, and cognitive impairment (p < 0.001). However, medication use had no significant association with the senior's age, marital status, education level, living status, substance abuse, and health insurance (p < 0.05). The risk of polypharmacy was 2.15 times higher in the elderly women than men (p = 0.001) and 0.45 times higher in participants with depression than non-depressed seniors (p = 0.011).
Conclusion: The high prevalence of polypharmacy indicates an unfavorable status of medication use among older adults in Kerman. So, authorities are required to provide educational information about polypharmacy to aged groups.
Type of Study: Research |
Subject:
Special
Received: 2022/01/31 | Accepted: 2023/06/25 | Published: 2023/06/20
Received: 2022/01/31 | Accepted: 2023/06/25 | Published: 2023/06/20
References
1. Mohammadi Shahboulaghi F, Karbalaee Z, Zarghi A, Moghaddam AG, Mohammadi M. Lifestyle of the elderly and its predictive factors. Journal of Research in Medical and Dental Science. 2018; 6(1): 219-25.
2. Aboozadeh Gotabi K, Ghanbari Moghaddam A, Mohammadi M, Zarei F. The burden of family caregivers caring for older adults and its relationship with some factors. Nursing Journal of the Vulnerable. 2016; 3(6): 27-36. [Persian]
3. Hanlon JT, Semla TP, Schmader KE. Alternative medications for medications in the use of high-risk medications in the elderly and potentially harmful drug-disease interactions in the elderly quality measures. Journal of the American Geriatrics Society. 2015; 63(12): e8–e18.
4. Dadashihaji A, Rahimi A, Hosseini SR, Moghadamnia AA, Bijani A. Inappropriate medication use and related factors in the elderly living in Northern Iran. Salmand: Iranian Journal of Ageing. 2021; 15(4): 440-57. [Persian]
5. Ahmadi B, Alimohamadian M, Mahmoodi M. Polypharmacy among older adults in Tehran. Tehran University Medical Journal. 2006; 64 (9): 65-71. [Persian]
6. Talebi Taher M, Javad Moosavi SA, Taherian S, Barati M. Surveying the inappropriate drug administration using beers criteria in elderly patients at the internal medicine ward of Rasoul-E-Akram Hospital of Tehran in 2012. Journal of Arak University of Medical Sciences. 2014; 17 (2): 33-9. [Persian]
7. Lim LM, McStea M, Chung WW, Nor Azmi N, Abdul Aziz SA, Alwi S, et al. Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia. PloS One. 2017; 12(3): e0173466.
8. Mutnick AH, Souney PF, Swanson LN, Shargel, L. Comprehensive pharmacy review for NAPLEX: practice exams, cases, and test prep. United States: Lip pincott Williams & Wilkins; 2012.
9. Bakhshi E, Delbari A, Saboor M, Akbari Kamrani AA, Yavari HR, et al. Prevalence of poly pharmacy among the elderly residents of Kahrizak charity foundation (KCF), Tehran, 2010-2011. Journal of Sabzevar University of Medical Sciences. 2013; 20(1): 42-50. [Persian]
10. Vali L, Pourreza A, Foroushani A, Sari A, Hooshyar D, Pharm H. An investigation on inappropriate medication applied among elderly patients. World Applied Sciences Journal. 2012; 16(6): 819-825.
11. Wongpakaran N, Wongpakaran T, Van Reekum R. Social inhibition as a mediator of neuroticism and depression in the elderly. BMC Geriatrics. 2012; 12(41): 1-7.
12. Torabi B, Mohammadi M, Aboozade Gatabi KH, Ghanbari Moghaddam A. Study of prescribing unsuitable drugs and polypharmacy in the elderly admitted to the Vasei Hospital of Sabzevar, 2017, Journal of Gerontology. 2018; 3(1): 48-55. [Persian]
13. Kim HA, Shin JY, Kim MH, Park BJ. Prevalence and predictors of polypharmacy among Korean elderly. PLoS ONE. 2014; 9(6): e98043.
14. Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading, but manageable. Clinical Interventions in Aging. 2008; 3(2): 383–9.
15. Chan DC, Hao YT, Wu SC. Characteristics of outpatient prescriptions for frail Taiwanese elders with long-term care needs. Pharmacoepidemiology and Drug Safety. 2009; 18(4): 327–34.
16. Yuruyen, M, Yavuzer, H, Demirdag F, Kara Z, Cengiz, M, Yavuzer S, et al. Is depression a predictive factor for polypharmacy in elderly?. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 2017; 26(4): 374-81.
17. Atari M, Yaghoubirad M. The big five personality dimensions and mental health: The mediating role of alexithymia. Asian Journal of Psychiatry. 2016; 24: 59–64.
18. Torabi S, Shahriari L, Zahedi R, Rahmanian S, Rahmanian K. A survey the prevalence of sleep disorders and their management in the elderly in Jahrom City, 2008. Journal of Jahrom University of Medical Sciences. 2013; 10(4): 35-41.
19. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 2005; 53(4): 695–9.
20. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research. 1983; 17(1): 37–49.
21. Niwata S, Yamada Y, Ikegami N. Prevalence of inappropriate medication using Beer’s criteria in Japanese long-term care facilities. BMC Geriatrics. 2006; 6(1): 1-7.
22. Zargarzadeh A, Sadeghi K, Mirmoghtadaei P. Prescribing of potentially inappropriate medications to elderly people by medical specialists in Isfahan, Iran. Iranian Journal of Pharmaceutical Sciences. 2008; 4(4): 241-6.
23. Bahat G, Tufan F, Bahat Z, Aydin Y, Tufan A, Akpinar TS, et al. Assessments of functional status, comorbidities, polypharmacy, nutritional status and sarcopenia in Turkish community-dwelling male elderly. The Aging Male. 2013; 16(2); 67–72.
24. Delshad Noghabi A, Baloochi Beydokhti T, Shamshiri M, Shareinia H, Radmanesh R. Polypharmacy and its related factors among elderlies. Iranian Journal of Nursing. 2013; 26(83): 1-9.
25. Nygaard H, Naik M, Ruths S, Straand J. Nursing-home residents and their drug use: a comparison between mentally intact and mentally impaired residents - The Bergen district Nursing Home (BEDNURS) study. European Journal of Clinical Pharmacology. 2003; 59: 463-9.
26. Viswanathan H, Bharmal M, Thomas J. Prevalence and correlates of potentially inappropriate prescribing among ambulatory older patients in the year 2001: comparison of three explicit criteria. Clinical Therapeutics. 2005; 27(1): 88–99.
27. Fialová D, Topinková E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I, et al. Potentially inappropriate medication use among elderly home care patients in Europe. The Journal of the American Medical Association. 2005; 293(11): 1348–58.
28. Aparasu RR, Mort JR, Brandt H. Polypharmacy trends in office visits by the elderly in the United States, 1990 and 2000. Research in Social and Administrative Pharmacy. 2005; 1(3): 446–59.
29. Levy RH, Collins C. Risk and predictability of drug interactions in the elderly. International Review of Neurobiology. 2007; 81: 235-21.
30. Morteza-Semnani K, Saeedi M, Gharipour O. Evaluation of cardiovascular drugs interactions in insured prescriptions in Sari during the years 2000-2001. Journal of Mazandaran University of Medical Sciences. 2001; 11(32): 37-45. [Persian]
31. Lashkaripour K, Bakhshani NM, Hokmabadi S, Sajjadi SAR, SafarzadehSarasiyabi A. Postpartum depression and related factors: A 4.5 months study. Journal of Fundamentals of Mental Health 2012; 13(52): 404-12. [Persian]
32. Storandt M, Vanden Bos, GR. The Adult years: continuity and change. Amer Psychological Assn; 1988.
33. Izadi F, Adib Hajbaghery M, Kafai M. Determining disturbing factors of sleep quality among hospitalized elderly patients in Kashan hospitals, Iran 2009. Journal of Shahid Sadoughi University of Medical Sciences. 2013; 20(6): 688-98. [Persian]
34. Irwina AS, Amita A, Ifa, N. Quality of Sleep on the Elderly: A Systematic Review. Proceedings of the 8th International Nursing Conference “Education, Practice and Research Development in Nursing”; 2017.
35. Ashrafi H, Ansarin K, Hasanzadeh M, Jouyban A. Review on sleep disorders and their management. Medical Journal of Tabriz University of Medical Sciences and Health Services. 2018; 40(2): 95-105. [Persian]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
